SciSparc Ltd. - Ordinary Shares (NQ: SPRC )
0.3247
-0.0050
(-1.52%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 5, 2024
Add to My Watchlist
Press Releases about SciSparc Ltd. - Ordinary Shares
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
SciSparc Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
November 29, 2022
From SciSparc Ltd
Via GlobeNewswire
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
SciSparc Gains Competitive Edge with Additional U.S. Patent Granted
November 08, 2022
From SciSparc Ltd
Via GlobeNewswire
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
From SciSparc Ltd
Via GlobeNewswire
![](https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
From Traders News Source
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/share/586.jpg?v=0)
From Aegis Capital Corp.
Via AccessWire
Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028
May 26, 2022
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.